Skip to main content
. 2019 Dec 19;23(1):100789. doi: 10.1016/j.isci.2019.100789

Figure 3.

Figure 3

Examples of Gene-Editing Strategies in Current Clinical Trials

(A) In cancer, gene-editing targets PD-1 or CD7 in T cells to enhance immune responses.

(B) In patients with HIV, CCR5 is targeted in HSPCs to prevent HIV entry.

(C) In β-thalassemia and sickle cell disease, induction of fetal hemoglobin or correction of adult hemoglobin in HSPCs is used.

(D) AAV-mediated gene editing in the liver provides circulating enzymes in lysosomal storage diseases.